Zealand Pharma enters AI partnership with Iktos
The French startup specialized in using artificial intelligence in drug design will help Zealand Pharma investigate new potential peptide-based drugs.
by mikkel aabenhus hemmingsen, translated by daniel pede
Danish pharmaceutical firm Zealand Pharma is not new to developing peptide-based drugs, but is now adding another tool to its toolbox by partnering up with Iktos, a French startup company specialized in artificial intelligence, according to a press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
